http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2754997-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf8ddd7435c69cd1b353b1292981d68 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
filingDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3a14fbbbcdc84ebba4e5ce13c3e81b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8ebaccd611711ef2ecf6662acc8e95a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e81cdb0160b2acd7dc84e260f8291b04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8746f6ed9ebb3ccc34c2c3d332d765e4 |
publicationDate | 2021-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2754997-C2 |
titleOfInvention | Treatment of focal alopecia |
abstract | FIELD: pharmaceutics.SUBSTANCE: present group of inventions relates to the field of pharmaceutics, namely to the use of a compound of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3,4]octane-1-yl]-3-oxopropannitrile for the preparation of a drug for the treatment of focal alopecia, as well as to the use of a composition containing the above-mentioned compound as an active ingredient for the preparation of the drug for the treatment of prevention of focal alopecia. In addition, a method for the treatment of focal alopecia in a subject, who needs it, is described, including a stage of injection to the specified subject of therapeutically effective amount of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3,4]octane-1-yl]-3-oxopropannitrile.EFFECT: providing a new pharmaceutical application of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3,4]octane-1-yl]-3-oxopropannitrile as a therapeutic or preventive agent for focal alopecia.22 cl, 2 dwg, 3 ex |
priorityDate | 2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.